Ravulizumab in Atypical Hemolytic Uremic Syndrome: Final Analysis of Efficacy and Safety Outcomes in Two Phase 3 Trials

Authors: Bradley P. Dixon, David Kavanagh, Brigitte Adams, Hee Gyung Kang, Edward Wang, Katherine Garlo, Masayo Ogawa, Spero R. Cataland, Yoshitaka Miyakawa, Yosu Luque, Veronica Taylor, Larry A. Greenbaum

Published: 2024-10-28

DOI: 10.1681/asn.20240n9ztps3

Keywords: No keywords found.

Abstract:
No abstract found.

Source: